HRA Pharma Clinical Trials
Sponsors / HRA Pharma
ClinicalTrials.gov lists 17 trials for which HRA Pharma is named as lead sponsor. The portfolio currently includes 0 recruiting studies, 1 active non-recruiting studies, and 13 completed studies. 2 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include safety concerns. Cumulative planned enrollment across all listed trials is 7,519 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
17
Total Trials
0
Recruiting
1
Other Active
13
Completed
2
Terminated / Withdrawn
7,519
Total Enrollment
Termination reasons: Other50% · Safety50%
Recent Terminations
- Contraception"Terminated prematurely due to issues with one of the data collection systems, no impact on subject safety"
- Cushing's Syndrome
Active Trials (1 total)
- NCT05255900